Erythropoietic protoporphyria with fatal liver failure

Ishibashi, Akiko; Ogata, Riko; Sakisaka, Shotaro; Kumashiro, Ryukichi; Koga, Yuriko; Mitsuyama, Keiichi; Kuromatsu, Ryoko; Uchimura, Yasuyo; Ijyuin, Hiroyasu; Tanaka, Kumi; Iwao, Tadashi; Ishii, Kunihide; Sata, Michio; Inoue, Yoshiko; Kin, Yasuko; Oizumi, Kotaro; Nishida, Hidemi; Imaizumi, Tsutomu; Tanikawa, Kyuichi; Ishibashi, A
June 1999
Journal of Gastroenterology;1999, Vol. 34 Issue 3, p405
Academic Journal
journal article
A 33-year-old woman with a history of photosensitivity, persistent abdominal pain, and liver dysfunction was admitted to our department because of abdominal pain and progression of liver dysfunction. On admission, levels of protoporphyrin and coproporphyrin within erythrocytes were markedly increased. Autofluorescent erythrocytes were also detected, leading to a diagnosis of erythropoietic protoporphyria. A liver biopsy specimen revealed cirrhosis with dark brown granules filling hepatocytes, bile canaliculi, and bile ductules. Transfusion of washed erythrocytes, hemodialysis, and administration of cholestyramine and beta-carotene transiently improved levels of porphyrins and liver function. The patient died of rupture of esophageal varices followed by multiple organ failure. However, the treatments were believed to have extended survival.


Related Articles

  • Liver Dysfunction Assessed by Model for End-Stage Liver Disease Excluding INR (MELD-XI) Scoring System Predicts Adverse Prognosis in Heart Failure. Abe, Satoshi; Yoshihisa, Akiomi; Takiguchi, Mai; Shimizu, Takeshi; Nakamura, Yuichi; Yamauchi, Hiroyuki; Iwaya, Shoji; Owada, Takashi; Miyata, Makiko; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Aims: Liver dysfunction due to heart failure (HF) is often referred to as cardiac or congestive hepatopathy. The composite Model for End-Stage Liver Disease excluding INR (MELD-XI) is a robust scoring system of liver function, and a high score is associated with poor prognosis in advanced HF...

  • Early use of TIPS in patients with cirrhosis and variceal bleeding. Carlos Garcia-Pagán, Juan; Bosch, Jaime; Korula, Jacob // ACP Journal Club;11/16/2010, Vol. 153 Issue 5, p12 

    A letter to the editor is presented in response to the article "Early use of transjugular intrahepatic portosystemic shunts (TIPS) in patients with cirrhosis and variceal bleeding," that was published in the previous issue.

  • Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis. Tajiri, Kazuto; Tokimitsu, Yoshiharu; Ito, Hiroyuki; Atarashi, Yoshinari; Kawai, Kengo; Minemura, Masami; Yasumura, Satoshi; Takahara, Terumi; Shimizu, Yukihiro; Sugiyama, Toshiro // Digestive Diseases;Jul2018, Vol. 36 Issue 4, p314 

    Aims: The study aimed to evaluate the effects of tolvaptan treatment on survival of patients with decompensated liver cirrhosis with refractory ascites. Methods: This multicenter, retrospective, observational study included patients with cirrhosis who were treated with...

  • The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis. Borhofen, Sarah; Gerner, Carmen; Lehmann, Jennifer; Fimmers, Rolf; Görtzen, Jan; Hey, Beate; Geiser, Franziska; Strassburg, Christian; Trebicka, Jonel; Borhofen, Sarah Maria; Görtzen, Jan; Strassburg, Christian P // Digestive Diseases & Sciences;Jun2016, Vol. 61 Issue 6, p1735 

    Background and Aims: Malnutrition might affect survival and severity of complications in cirrhotic patients. However, adequate evaluation of the nutritional status is a difficult task since the common assessment tools are either inappropriate or too complicated. A simpler method...

  • HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection. Sarrazin, Christoph; Castelli, Francesco; Andreone, Pietro; Buti, Maria; Colombo, Massimo; Pol, Stanislas; Calinas, Filipe; Puoti, Massimo; Olveira, Antonio; Shiffman, Mitchell; Stern, Jerry O.; Kukolj, George; Roehrle, Michael; Aslanyan, Stella; Qiqi Deng; Vinisko, Richard; Mensa, Federico J.; Nelson, David R. // Clinical & Experimental Gastroenterology;Nov2016, Vol. 9, p351 

    The interferon-free combination of once-daily faldaprevir 120 mg, twice-daily deleobuvir 600 mg, and weight-based ribavirin was evaluated in two Phase III studies (HCVerso1, HCVerso2) in hepatitis C virus genotype-1b-infected, treatment-naïve patients, including those ineligible for...

  • Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection. Zeuzem, Stefan; Ghalib, Reem; Reddy, Rajender; Pockros, Paul J.; Ben Ari, Ziv; Yue Zhao; Brown, Deborah D.; Shuyan Wan; DiNubile, Mark J.; Bach-Yen Nguyen; Robertson, Michael N.; Wahl, Janice; Barr, Eliav; Butterton, Joan R. // Annals of Internal Medicine;7/7/2015, Vol. 163 Issue 1, p1 

    Background: Novel interferon- and ribavirin-free regimens are needed to treat hepatitis C virus (HCV) infection. Objective: To evaluate the safety and efficacy of grazoprevir (NS3/4A protease inhibitor) and elbasvir (NS5A inhibitor) in treatment-naive patients. Design: Randomized, blinded,...

  • Hepatitis C virus infection: signs, symptoms, and screening. WONG, REBECCA; RUSSELL, CYNTHIA; KRUGER, DANIELLE // Clinical Advisor;Feb2016, Vol. 19 Issue 2, p37 

    No abstract available.

  • Abdominal distension and upper extremity muscle wasting in a 59-year-old woman. Kinzel, Julie // JAAPA: Journal of the American Academy of Physician Assistants (;Jun2014, Vol. 27 Issue 6, p59 

    No abstract available.

  • Coagulopathy in fulminant liver failure with ultimately fatal clot formation. Kennelly, Patrick; Farrell, Terence; Martin-Loeches, Ignacio; Kennelly, Patrick John // Intensive Care Medicine;Oct2016, Vol. 42 Issue 10, p1628 

    The article presents a case study of a 57-year old man with known liver cirrhosis who was admitted to the emergency department because of malaise, who, on admission, was jaundiced and was with chronic liver failure stigmata. Clinical examinations revealed encephalopathy grade 2 and after...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics